We are well established as a global hub in terms of volume and growth, but our ultimate goal is to be globally acknowledged as the best…
In Conversation
The revenue coming from emerging markets is expanding every year. The company believes that there is enough potential from these markets to grow at an even…
Morocco has been a pioneer in the region in the field of immunization by introducing innovative vaccines in the national immunization program and by achieving very…
We were the first group to start a country-wide expansion, from Saudi Arabia we expanded to the region and we have the vision to be present…
Despite the lack of visibility on approval timelines, we are already running clinical trials locally, because we are convinced about the high value clinical trials can…
Our major focus when creating Gynebio Pharma was creating a company and a production facility that would benefit Morocco, but also Africa and the Middle East;…
About 38.7 million adults between the ages of 20 to 79 [in the MENA region] are currently diabetic, which means that, by 2040, about 82 million…
The market being stagnant, prices are dropping and competition is rising. It is, therefore, crucial to define the right growth channel, such as exports, as Morocco…
In the UAE and across the GCC, where NCDs represent a significant hurdle for the healthcare system, our strategy is to foster meaningful partnerships with the…
Servier has been present in Morocco since the 1970s, and next year we are going to celebrate our 25th anniversary as an affiliate here!
Layla Laassel Sentissi – Executive Director, Moroccan Association of the Pharmaceutical Industry (AMIP)

Out of 280 foreign companies with products on the Moroccan market, 260 market their products in partnership with AMIP members
Our vision was to create a regional platform ready to license, market and commercialize innovation from companies that did not want to be in the region…